Skip to main content
    C

    Centene Corp (CNC)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NYSE

    $74.78
    +3.51 (+4.92%)

    Market Cap: $35.28B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Centene Corp (CNC) Earnings: Report Dates and Results

    Updated Oct 27, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Centene (CNC) is expected to report earnings on Feb 4, 2027. In the quarter ended Sep 30, 2026, Centene reported EPS of $0.58, above the $0.07 estimate. It beat the EPS estimate in 7 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    85%(34/40)
    Avg Surprise
    +37.44%
    Streak
    5 Q

    Upcoming Estimates

    Reports Feb 4, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$1.16
    Range-$1.24 - -$0.99
    22 analysts
    Revenue Consensus
    $46.79B
    Range$43.44B - $51.99B
    18 analysts
    Reports Apr 26, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$3.38
    Range$1.28 - $4.55
    14 analysts
    EPS Estimate DriftChange to current
    90d ago$3.37+0.3%
    60d ago$3.37+0.3%
    30d ago$3.37+0.4%
    7d ago$3.37+0.4%
    Current$3.38
    Revenue Consensus
    $49.02B
    Range$47.80B - $51.28B
    8 analysts

    Next Report

    CNC has an expected report date of Feb 4, 2027.

    CNC Earnings Call

    The latest CNC earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, CNC beat 34, missed 5 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $50.65B, up 1.9% from $49.69B a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$0.58$0.07$0.00 - $0.33+728.57%Beat+16.0%190 up, 1 downOct 27, 2026$50.65B
    Jun 30, 2026$2.51$0.89$0.41 - $1.94+182.02%BeatN/A190 up, 0 downJul 28, 2026$53.58B
    Mar 31, 2026$3.37$2.13$0.41 - $2.89+58.22%Beat+16.2%182 up, 4 downApr 28, 2026$49.94B
    Dec 31, 2025-$1.19-$1.22-$1.30 - -$0.99+2.46%Beat-248.7%181 up, 2 downFeb 6, 2026$49.73B
    Sep 30, 2025$0.50-$0.16-$0.59 - $0.05+412.50%Beat-69.1%181 up, 0 downOct 29, 2025$49.69B
    Jun 30, 2025-$0.16$0.21-$1.02 - $1.54-176.19%Miss-106.6%14N/AJul 25, 2025$48.74B
    Mar 31, 2025$2.90$2.52$1.96 - $2.74+15.08%Beat+28.3%156 up, 0 downApr 25, 2025$46.62B
    Dec 31, 2024$0.80$0.49$0.43 - $0.58+63.27%Beat+77.8%162 up, 2 downFeb 4, 2025$40.80B
    Sep 30, 2024$1.62$1.41$1.27 - $1.55+14.89%Beat-19.0%150 up, 0 downOct 25, 2024$42.02B
    Jun 30, 2024$2.42$2.09$1.80 - $2.44+15.79%Beat+15.2%175 up, 0 downJul 26, 2024$39.84B
    Mar 31, 2024$2.26$2.08$1.90 - $2.26+8.65%Beat+7.1%170 up, 0 downApr 26, 2024$40.41B
    Dec 31, 2023$0.45$0.44$0.38 - $0.55+2.27%Beat-47.7%141 up, 0 downFeb 6, 2024$39.46B
    Sep 30, 2023$2.00$1.54$1.26 - $1.80+29.87%Beat+53.8%154 up, 0 downOct 24, 2023$38.04B
    Jun 30, 2023$2.10$2.05$1.69 - $2.53+2.44%Beat+18.6%192 up, 1 downJul 28, 2023$37.61B
    Mar 31, 2023$2.11$2.10$1.77 - $3.79+0.48%Beat+15.3%181 up, 0 downApr 25, 2023$38.89B
    Dec 31, 2022$0.86$0.84$0.78 - $1.37+2.38%Beat-14.9%170 up, 0 downFeb 7, 2023$35.56B
    Sep 30, 2022$1.30$1.23$1.12 - $1.40+5.69%Beat+3.2%181 up, 0 downOct 25, 2022$35.87B
    Jun 30, 2022$1.77$1.59$1.05 - $1.79+11.32%Beat+41.6%1912 up, 0 downJul 26, 2022$35.94B
    Mar 31, 2022$1.83$1.69$1.60 - $1.84+8.28%Beat+12.3%171 up, 0 downApr 26, 2022$37.19B
    Dec 31, 2021$1.01$0.97$0.95 - $1.15+4.12%Beat+119.6%171 up, 0 downFeb 8, 2022$32.57B
    Sep 30, 2021$1.26$1.23$0.74 - $1.62+2.44%Beat0.0%181 up, 2 downOct 26, 2021$32.41B
    Jun 30, 2021$1.25$1.37$1.15 - $2.15-8.76%Miss-47.9%19N/AJul 27, 2021$31.02B
    Mar 31, 2021$1.63$1.53$1.35 - $1.77+6.54%Beat+89.5%14N/AApr 27, 2021$29.98B
    Dec 31, 2020$0.46$0.47$0.36 - $0.54-2.13%Miss-37.0%15N/AFeb 9, 2021$28.29B
    Sep 30, 2020$1.26$0.96$0.89 - $1.05+31.25%Beat+31.3%18N/AOct 27, 2020$29.09B
    Jun 30, 2020$2.40$2.43$2.38 - $2.58-1.23%Miss+79.1%18N/AJul 28, 2020$27.71B
    Mar 31, 2020$0.86$0.99$0.88 - $1.34-13.13%Miss-38.1%17N/AApr 28, 2020$26.02B
    Dec 31, 2019$0.73$0.73$0.66 - $0.800.00%In line+5.8%21N/AFeb 4, 2020$18.86B
    Sep 30, 2019$0.96$0.95$0.91 - $1.02+1.05%Beat+6.7%19N/AOct 22, 2019$18.98B
    Jun 30, 2019$1.34$1.24$1.15 - $1.31+8.06%Beat+48.9%18N/AJul 23, 2019$18.36B
    Mar 31, 2019$1.39$1.35$1.04 - $1.41+2.96%Beat+27.5%20N/AApr 23, 2019$18.44B
    Dec 31, 2018$0.69$0.66$0.62 - $0.71+4.55%Beat+40.8%21N/AFeb 5, 2019$16.56B
    Sep 30, 2018$0.90$0.89$0.84 - $0.91+1.12%Beat+32.4%21N/AOct 23, 2018$16.18B
    Jun 30, 2018$0.90$0.88$0.85 - $1.00+2.27%Beat+12.5%20N/AJul 24, 2018$14.18B
    Mar 31, 2018$1.09$0.97$0.57 - $1.05+12.37%Beat+94.6%16N/AApr 24, 2018$13.19B
    Dec 31, 2017$0.49$0.46$0.42 - $0.49+6.52%Beat-18.3%19N/AFeb 6, 2018$12.81B
    Sep 30, 2017$0.68$0.62$0.56 - $0.67+9.68%Beat+21.4%16N/AOct 24, 2017$11.90B
    Jun 30, 2017$0.80$0.64$0.58 - $0.90+25.00%Beat+23.1%19N/AJul 25, 2017$11.95B
    Mar 31, 2017$0.56$0.52N/A+7.69%Beat+51.4%N/AN/AApr 25, 2017$11.72B
    Dec 31, 2016$0.60$0.55N/A+9.09%Beat+25.0%N/AN/AFeb 7, 2017$11.91B
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $2.05, down 71.1% from the year before. It was $2.18 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$2.05-71.1%
    Dec 31, 2024$7.10+6.6%
    Dec 31, 2023$6.66+15.6%
    Dec 31, 2022$5.76+11.8%
    Dec 31, 2021$5.15+3.4%
    Dec 31, 2020$4.98+12.7%
    Dec 31, 2019$4.42+23.5%
    Dec 31, 2018$3.58+41.5%
    Dec 31, 2017$2.53+16.1%
    Dec 31, 2016$2.18N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 9,300 words across 17 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20269,29617
    2026Q2Jun 30, 20269,86116
    2026Q1Mar 31, 20268,70817
    2025Q4Dec 31, 20259,42615
    2025Q3Sep 30, 20258,56115
    2025Q2Jun 30, 20259,83615
    2025Q1Mar 31, 20258,81018
    2024Q4Dec 31, 20246,87516

    2026Q3 Earnings Call

    Opening remarks

    Jennifer Lynch Gilligan Senior Vice President, Investor Relations Thank you, Rocco, and good morning, everyone. Thank you for joining us on our third quarter 2026 earnings results conference call. Sarah London, Chief Executive Officer, and Drew Asher, Executive Vice President and Chief Financial Officer of Centene, will host this morning's call, which can also be accessed through our website at centene.com. Any remarks that Centene may make about future expectations, plans, and prospects constitute forward-looking statements for the purpose of the Safe Harbor provision under the Private Securities Litigation Reform Act of 2000. Specifically, our commentary on our full-year 2026 outlook, including the drivers of such outlook, are forward-looking statements. Actual results may differ materially from those indicated by those forward-looking statements as a result of various important factors, including those discussed in our third quarter 2026 press release and other public SEC filings, which are available on the company's website under the Investors section. Centene anticipates that subsequent events and developments may cause its estimates to change. While the company may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. The call will also refer to certain non-GAAP measures. A reconciliation of these measures with the most directly comparable GAAP measures can be found in our third quarter 2026 press release. With that, I would like to turn the call over to our CEO, Sarah London. Sarah?

    Sarah London CEO Thanks, Jennifer, and thank you all for joining us to review Centene's third quarter results. This morning, we reported third quarter adjusted diluted earnings per share of $0.58, ahead of our previous expectations. These results, driven by outperformance in our Medicare segment and in-line performance from our Medicaid and commercial businesses, support an improved full-year financial outlook. We now expect 2026 adjusted diluted earnings per share of more than $5.20. As we remain focused on disciplined execution to finish the year strong, we are excited to carry the positive momentum we are producing across our businesses into 2027. Let's unpack the results by business line, starting with Medicaid. Our Medicaid business is right on track for the quarter, reflecting the positive rate actions highlighted during our second quarter call and effective execution against key quality and affordability initiatives, including member and provider engagement, network management, and a diverse portfolio of fraud, waste, and abuse interventions. We reported a Medicaid HBR of 93.6%, improving sequentially by 30 basis points from Q2 and keeping pace with our trajectory to achieve a full-year Medicaid HBR of 93.5%.

    Frequently Asked Questions About CNC

    When is Centene's next earnings date?

    Centene's next earnings report is expected for Feb 4, 2027.

    Did CNC beat earnings estimates last quarter?

    Yes. Centene reported EPS of $0.58 for the quarter ended Sep 30, 2026, above the $0.07 estimate, a 728.57% surprise.

    What EPS do analysts expect from CNC next quarter?

    The consensus EPS estimate for Centene for the quarter ending Dec 31, 2026 is -$1.16 from 22 analysts, with estimates from -$1.24 to -$0.99.

    How often does CNC beat earnings estimates?

    Centene beat the EPS estimate in 7 of the last 8 quarters, with an average surprise of +160.74%.